Pee Safe, an India-based women’s hygiene and wellness company, has raised $32 million (approximately Rs 290 crore) in Series C funding led by OrbiMed. The round includes a mix of primary capital and secondary share sales, allowing some early investors to partially exit.
OrbiMed, a healthcare-focused private equity firm with approximately $20 billion under management, will take board seats at Pee Safe, with Dr. Sunny Sharma and Sumona Chakraborty joining the company’s board.
Founded by Vikas Bagaria and Rithish Kumar, Pee Safe initially built its brand around toilet seat sanitiser sprays, addressing hygiene gaps in public restrooms – a category largely absent in India a decade ago. The company has since expanded into feminine and intimate hygiene, personal care, grooming, and wellness.
The company has an omnichannel presence across more than 50,000 offline retail touchpoints in over 100 cities, alongside distribution through online platforms and exports to 23 international markets.
The funding will be used to expand offline retail distribution, strengthen marketing, and accelerate growth across quick commerce platforms and ecommerce marketplaces.
“Pee Safe was founded to address a deeply underserved women’s health category and challenge long-standing taboos,” said Bagaria, adding that the startup’s focus on disciplined execution had allowed it to scale profitably.
Kumar said the partnership with OrbiMed would help the company build a more robust omnichannel growth engine, particularly as consumer discovery increasingly shifts towards instant delivery platforms.
Dr. Sunny Sharma, Senior Managing Director at OrbiMed Asia, said: “Pee Safe has built a differentiated brand with strong consumer loyalty in large categories,” adding that the firm sees significant headroom for growth as hygiene and wellness adoption deepens across India.
